Aviva PLC Altimmune, Inc. Transaction History
Aviva PLC
- $34.3 Billion
- Q2 2024
A detailed history of Aviva PLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Aviva PLC holds 22,954 shares of ALT stock, worth $140,937. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,954
Previous 22,954
-0.0%
Holding current value
$140,937
Previous $233,000
34.76%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ALT
# of Institutions
191Shares Held
42.4MCall Options Held
1.05MPut Options Held
582K-
Black Rock Inc. New York, NY5.32MShares$32.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$30.1 Million0.0% of portfolio
-
State Street Corp Boston, MA3.91MShares$24 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN3.22MShares$19.8 Million0.01% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$16.9 Million2.23% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $301M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...